Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
mRNA | SIRT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-09 |
mRNA | SEZ6 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
mRNA | ZNF785 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | SLC25A29 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | GAL3ST4 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |